Home » Newsletters » BioWorld

BioWorld

March 29, 1994

View Archived Issues

DAHI RECEIVES $2.5 MILLION LOAN FROM DEPRENYL

PROGENITOR EXPANDS GENE THERAPY POTENTIAL

EUROPEAN PATENT DISCLOSURES PUBLISHED MARCH 9 & 16 (EPO); MARCH 3 (WO)

BIOSEPRA'S IPO RAISES $21M

CERESTAT SHOWS PROMISE IN TBI

GLIATECH STARTS U.S. TRIALS

IMMUNOTHERAPEUTICS MAY LICENSE DRUG FOR CANCER

SUIT AGAINST AMGEN DISMISSED

ATOMIC STRUCTURE OF TUMOR DRUG-RESISTANCE FACTOR SOLVED

STARK PLAN PROCEEDS TO WAYS AND MEANS COMMITTEE

GUILFORD FILES IPO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026